Which Small Cap ETF Is the Better Buy in 2026? iShares and JPMorgan Have Compelling Offerings

The article compares JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC) vs iShares Morningstar Small-Cap ETF (ISCB): BBSC holds 728 positions vs ISCB’s 1,557 and charges a higher 0.09% expense ratio (vs 0.04%). BBSC also shows stronger recent performance with a 1-yr total return of 35.8% vs 27.8% for ISCB, and the article notes BBSC is up about 24% YTD vs 16.8% for ISCB. On income, ISCB pays a higher trailing yield (1.30% vs ~1.00% for BBSC), while both have similar max drawdowns over 5 years (~30%).

Analysis

This is more a distribution/flow story than a fundamentals story. The only durable winner is the issuer with the stronger channel and the ETF that can keep gathering assets after the recent small-cap rebound; the fee gap is small in dollar terms, but over time it compounds enough to matter for adviser model portfolios. That said, this is not material enough to move JPM shares, so any "benefit" to the bank is strategic rather than P&L-sensitive.

For the underlying holdings, the more concentrated sleeve creates a short-horizon bid to a narrower set of higher-beta names, especially semi/tech and selected growth healthcare. That helps single names like SMTC, FORM, OKTA, and GH at the margin when small-cap momentum is strong, but it also means factor crowding can unwind quickly if breadth expands or liquidity conditions tighten. The broader basket is the better vehicle if the next leg of the trade is a broadening rally rather than a continuation of narrow leadership.

Contrarian take: the market is likely over-anchoring on trailing relative performance, which is often the least durable input for small-cap ETFs. The real catalyst is rates and credit spreads; if real yields stay sticky or bank lending standards tighten, the higher-beta, more concentrated exposure should give back faster, while the cheaper diversified fund should win over a 6-18 month horizon as fee drag and mean reversion matter more than recent momentum.

Key Decisions for Investors

• No immediate trade in JPM from this ETF comparison; the AUM/fee impact is too small to be earnings-relevant. Treat any JPM benefit as watchlist-only unless small-cap ETF flows accelerate materially over the next 1-2 quarters.
• For core small-cap exposure, prefer ISCB over BBSC on a 6-18 month horizon if you want lower fee + broader breadth. Add on pullbacks rather than chasing after the recent run-up; thesis breaks if BBSC keeps outperforming ISCB by another 5%+ over the next quarter without a breadth expansion.
• Tactical relative-value idea: long ISCB / short BBSC only if the next macro leg is lower real yields and broader small-cap participation. Target 3-5% relative outperformance in 1-3 months; stop if the Russell 2000 rally remains narrow and BBSC continues to win on momentum.
• If you want single-name beta from the concentrated basket, use SMTC/FORM as higher-volatility expressions rather than the ETF itself; downside risk is larger if small-cap liquidity weakens. Falsifier: credit spreads widen or 10Y real yields move higher, which would hit the concentrated sleeve first.